Below are the best resources we could find on MDMA featuring rick doblin.
CLEAR ALL
Written by the world's leading experts on MDMA, Ecstasy: The Complete Guide takes the first unbiased look at the risks and the benefits of this unique drug, including the science of how it works; its promise as a treatment for depression, post-traumatic stress disorder, chronic pain, and other...
The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.
Rick Doblin - "Psychedelics: Mystical Experiences, Cultural Evolution, Non-Profit MDMA/PTSD Research, and Burning Man" Rick Doblin, the co-founder and CEO of the Multidisciplinary Association for Psychedelic Studies (MAPS, www.maps.
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
1
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
Featuring essays and interviews with Timothy Leary, Aldous Huxley, Ram Dass and others, this one-of-a-kind anthology published by the Multidisciplinary Association for Psychedelic Studies (MAPS), includes topics such as the healing use of marijuana and psychedelics for PTSD, anxiety, depression,...
2
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.